We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Technology

Grow

Status: Extended

Aug 13th 2021 - Sep 8th 2021

Grow is a British biopharmaceutical company on a mission to unlock the potential of cannabis medicines for patients globally. It claims that it is one of the largest importers of cannabis medicines in the UK and Ireland since its founding in 2017. The company has raised over £9.5 million through several fundraising rounds to allow expansion of operations, supplied medicines to more than 1,200 patients a month as of June 2021, and earned £2.35 million in revenue as of July 20, 2021. The company has also launched its patient app, Calyx, to help patients track their medications and health indicators and signed long term partnerships with some of the world’s leading cannabis companies, including Aurora, Tilray and Columbia Care. The company argues that it has also pioneered the ‘Open Cannabis’ campaign to improve education on cannabis medicines and the means to access them in the UK. It states it will use 40% of the investment on capital expenditure, 30% on hiring new personnel, and 30% as working capital.

read more read less

Grow Rating Review

Pitch rating powered by CROWDRATING

Rated on 27/08/2021

Pitch Rated

53%

Insufficient Data

Management

80%

Product

80%

Investment

UNRATED*

* Section unrated owing to insufficient or incomplete information available at the time of rating.

Log in to view amount pledged

    Log in to view target

    £66,018,405
    pre-money valuation

    4.62%
    equity available

    691
    investors

    £5,161
    pledge per investor

    11056972
    company number

    Active
    company status

    09/11/2017
    incorporated 7 years

    Previous Funding rounds
    26 Apr 24 Seedrs £3,566,133 / 111% 53.33%

What the ratings mean

  • 49% and under
    We suggest potential investors carry out further study of their own
    50-64%
    Room for improvement
    65-79%
    Worth considering
    80%+
    Gold rating, our highest rating

RISK WARNING - The ratings are based on the information provided in the fund raiser’s pitch deck, business plans and financial forecasts which have appeared on a FCA regulated crowdfunding site. Where possible we validate the business plan to public sources such as LinkedIn, Companies House, Credit Agencies and internet searches. We cannot guarantee the information is correct. The ratings report takes no account of the investors/ individual circumstances. Do your own due diligence and get professional advice before investing. Your capital is at risk when investing in private companies.

Login to view the full report

Management 80%

Skills 82%
The management team includes skilled professionals with a passion for improving the cannabis medicine market and boosting innovation in the sector. As per the profiles listed publicly and on LinkedIn, the Founder/CEO is skilled in investment banking, credit risk, financial structuring, trading, commodity risk management, and venture financing. He is regularly featured on Sky News, Bloomberg, BBC, and The Financial Times. The CSO is skilled in product development, medical devices, biotechnology, commercialisation, genomics, biochemistry, life sciences, and healthcare. The CTO is proficient in software development, web & application development, UI, UX, CRM, agile methodologies, business development, project management, and integration. The COO specialises in transforming corporate functions across procurement, HR, finance, and IT, from creation, centralisation, or outsourcing, including processes and systems to support the business requirements. The Head of Material Sciences is skilled in chemistry, coatings, nanomaterials, polymers, composites, and risk assessment. The Head of Chemistry Research is skilled in chemistry, organic synthesis, spectroscopy, purification, organic chemistry, and biochemistry. The CFO is a qualified accountant skilled in management reporting, financial planning, financial modelling, accounting, and project management.

0 comments

Log in to comment


Funding progress

Log in to view funding progress.


More from Technology

Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Extended investment: £1,014,708
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go: Stretch investment: £788,519
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.  Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go: Extended investment: £87,500
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go: Extended investment: £150,000

Log in to view amount pledged

    Log in to view target

    £66,018,405
    pre-money valuation

    4.62%
    equity available

    691
    investors

    £5,161
    pledge per investor

    11056972
    company number

    Active
    company status

    09/11/2017
    incorporated 7 years

    Previous Funding rounds
    26 Apr 24 Seedrs £3,566,133 / 111% 53.33%
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph